Tag: RSV (respiratory syncytial virus)

Contracting RSV Before Age 2 Can Cause Long-term Lung Changes and Impairment

sarah JonasResearch Results

Infants and children who have severe cases of respiratory syncytial virus (RSV) before age 2 are likely to have changes to their lung structure and function that could affect respiratory health later in life.

Study Could Help Clear Up Confusion and Hesitancy Surrounding RSV Vaccines

sarah JonasResearch Alert

Efforts to vaccinate vulnerable populations against respiratory syncytial virus (RSV) faced an uphill battle this season. However, now a new study by researchers at New York Institute of Technology College of Osteopathic Medicine (NYITCOM) could help to combat RSV vaccine misinformation and quell vaccine…

Pharmacology Expert Comments on RSV Vaccination Errors

sarah JonasExpert Pitch

The Centers for Disease Control and Prevention (CDC) reports that some pregnant Americans may have been given the wrong RSV vaccine, and some young children received a vaccine approved for use in adults only.  Now, a pharmacology expert at New York Institute…

MSU expert: What to know about flu, RSV, new COVID-19 variant and new vaccine

sarah JonasFeature Expert

The new COVID-19 EG.5 variant is responsible for around 22% of current cases. The World Health Organization has classified it as a “variant of interest,” meaning countries should monitor it more closely than other strains — and cases have only increased in the past few weeks. Peter Gulick is an expert on infectious diseases, and he provides insight on what this new variant could mean and what you should know.

Getting vaccines for flu, RSV, pneumonia and COVID.

sarah JonasExpert Pitch

David Winter, MD, at Baylor Scott & White Health, answers the most common patient questions and reacts to the latest medical research. With flu season approaching, who should get a flu shot and when? (SOT@ :14, TRT :24) RSV cases…

Commentary: Newest vaccination recommendations provide more protection against RSV

sarah JonasExpert Pitch

Earlier this summer, the Advisory Committee on Immunization Practices (ACIP) at the U.S. Centers for Disease Control and Prevention (CDC) voted in favor of a recommendation that adults 60 years and older receive a single dose of respiratory syncytial virus (RSV) vaccine, using shared clinical decision-making. Two new vaccines – RSVpreF (ABRYSVO) by Pfizer and RSVPreF3 (Arexvy) by GSK – are approved for use in this population and show robust protection against RSV. As several vaccines emerge offering protection to both the old and the very young, ACIP member Camille Nelson Kotton, MD, says this is an exciting time for RSV prevention.

Dr. Carol Nwelue discusses how to keep your kids healthy when going back to school.

sarah JonasExpert Pitch

Carol Nwelue, MD, at Baylor Scott & White Health, answers common patient questions and reacts to the latest medical research. How can parents keep their kids healthy this back-to-school season? (SOT@ 0:14, TRT 0:34) Why do sicknesses spread easily when…